This stems from the lack of a suitable animal model beyond the digenic Sap130 and Pcdha9 mutant models [12], primarily restricting the understanding of genetic mutations and HLHS onset and keeping the findings chiefly restricted to transcriptomic and in vitro studies. The gene discussed is PCDHA9; the disease is hypoplastic left heart syndrome.